Blog
About

0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Survival, Mode of Death, Reinfarction and Use of Medication during a Period of 5 Years after Acute Myocardial Infarction in Different Age Groups

      , , ,

      Cardiology

      S. Karger AG

      Acute myocardial infarction, Age, Long-term prognosis

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We describe the prognosis during 5 years of follow-up among consecutive patients hospitalized in a single hospital due to acute myocardial infarction in various age groups. When considering various aspects of clinical history, age was the strongest independent predictor of total 5-year mortality and of 5-year mortality after discharge from hospital. The overall 5-year mortality was: age < 65, 23%; age 65-75, 49%; age > 75, 79% (p < 0.001). The relationship between age and death appeared to be similar regardless of the development of Q waves, infarct size and infarct site. Among patients who died, younger patients more frequently died a sudden death associated with ventricular fibrillation, whereas the elderly more frequently died in association with congestive heart failure.

          Related collections

          Author and article information

          Journal
          CRD
          Cardiology
          10.1159/issn.0008-6312
          Cardiology
          S. Karger AG
          0008-6312
          1421-9751
          1996
          1996
          19 November 2008
          : 87
          : 6
          : 529-536
          Affiliations
          Division of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden
          Article
          177150 Cardiology 1996;87:529–536
          10.1159/000177150
          8904682
          © 1996 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 8
          Categories
          Coronary Care

          Comments

          Comment on this article